Àüü
Çà»ç
Àλç
ºÎÀ½
È­ÃË
µ¿Á¤
ÀÌÀü
Þäͱ
µ¿Á¤
ÇãÁØ¿µ ±³¼ö, Çѱ¹¾ÏÇмúÀç´Ü Çмú»ó ¼ö»ó
ÇѾç´ëÇб³±¸¸®º´¿ø Ç÷¾×Á¾¾ç³»°ú ÇãÁØ¿µ ±³¼ö°¡ ´ëÇÑÁ¾¾ç³»°úÇÐȸ¿¡¼­ ÀÓ»ó ¾Ï ¿¬±¸ ºÐ¾ßÀÇ ³í¹®À¸·Î ¡®2020³â Çѱ¹¾ÏÇмúÀç´Ü Çмú»ó¡¯À» ¼ö»óÇß´Ù.

ÇãÁØ¿µ ±³¼ö´Â Oncoimmunology (IF=5.33)¿¡ °ÔÀçµÈ 'Immune-related adverse events are clustered into distinct subtypes by T-cell profiling before and early after anti-PD-1 treatment' ¶ó´Â Á¦¸ñÀÇ ³í¹®À¸·Î À§ »óÀ» ¼ö»óÇß´Ù.

Çã ±³¼ö´Â ¡°¸é¿ªÇ×¾ÏÁ¦ Åõ¿© ÀüÈÄ T¸²ÇÁ±¸ÀÇ º¯È­ÆÐÅÏÀ» ÅëÇÏ¿© ¸é¿ªÇ×¾ÏÁ¦ ºÎÀÛ¿ëÀÇ ±âÀüÀ» ¹àÈ÷°íÀÚ ÇÑ ³í¹®À¸·Î, À̹ø ¿¬±¸ °á°ú¸¦ Åä´ë·Î ¸é¿ªÇ×¾ÏÁ¦ °ü·Ã ºÎÀÛ¿ëÀ» Ä¡·áÇÏ´Â ±Ù°Å¸¦ Á¦½ÃÇϰíÀÚ ÇÑ´Ù¡±°í ¼Ò°¨À» ¹àÇû´Ù.

ÇÑÆí, ÇãÁØ¿µ ±³¼ö´Â ÇѾç´ëÇб³ Àǰú´ëÇÐÀ» Á¹¾÷Çϰí, °æÈñ´ë ´ëÇпø¿¡¼­ ¼®»ç¿Í ¼º±Õ°ü´ë ´ëÇпø ¹Ú»ç ¼ö·á ¹× »ï¼º¼­¿ïº´¿ø Ç÷¾×Á¾¾ç³»°ú Àӻ󰭻縦 ¼ö·áÇÏ¿´À¸¸ç, ´ëÇѳ»°úÇÐȸ, ´ëÇѾÏÇÐȸ, ´ëÇÑÇ÷¾×ÇÐȸ, ´ëÇÑÁ¾¾ç³»°úÇÐȸ, ´ëÇÑÇ׾Ͽä¹ý¿¬±¸È¸, ¹Ì±¹¾Ï¿¬±¸ÇÐȸ (American Association for Cancer Research, AACR) µî¿¡¼­ Ȱ¹ßÇÑ È°µ¿À» Çϰí ÀÖ´Ù.
ÀÔ·ÂÀÏ : 2020-06-18